Alpha Tau Medical Ltd. (DRTS) 은(는) 상장 기업입니다 헬스케어 섹터의 바이오 산업에서 운영. 본사 소재지는 Jerusalem, Israel. 현재 CEO는 Uzi Sofer.
DRTS 을(를) 보유 IPO 날짜 2021-03-08, 125 명의 정규직 직원, 에 상장 NASDAQ Capital Marke, 시가총액 $689.12M.
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.
